Magnesium sulfate in the treatment of acute asthma

Completed

• Conditions: Acute asthma; Respiratory

• Registration Number: ISRCTN61336225
• Lead Sponsor: Alexandria University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2016-09-26
• Last Update Posted: 6 February 2017

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

1. Children diagnosed as asthmatic according to The Global Initiative for Asthma (GINA) guidelines
2. Aged 5-14 years old
3. Capable of measuring PEFR
4. Presenting with moderate to severe acute exacerbation according to pediatric asthma severity score and PEFR

Exclusion Criteria

1. Severely ill patients requiring immediate hospital care
2. Any evidence of respiratory tract infection or suppurative lung diseases
3. Any history of cardiac, renal or hepatic dysfunction
4. Use of short acting bronchodilator within 8 hours or long acting within 24 hours
5. Use of systemic steroids within 72 hours
6. Children known to have immunodeficiency
7. History of previous asthmatic attacks managed by ICU admissions

Study & Design

• Study Type: Interventional
• Study Design: Not specified